Effects of deferoxamine versus deferasirox on hematology and liver parameters in children with beta-thalassemia major: A cross-sectional study from a single center

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Al Nimer Marwan S.; Hamasalih Raz M.; Ratha Rawa

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY Year:2023 | Volume:13 | Issue:4 Page(s): 251-259

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Effects of deferoxamine versus deferasirox on hematology and liver parameters in children with beta-thalassemia major: A cross-sectional study from a single center

Author(s)

Al Nimer Marwan S. | Hamasalih Raz M. | Ratha Rawa | Issue Writer Certificate

Keywords

-thalassemia

Deferasirox

Deferoxamine

Liver fibrosis indices

Abstract

Background: Iron chelating agents (ICAs) may induce changes in the blood and the liver indices. This study aimed to compare the effects of deferasirox (oral) and deferoxamine (parenteral) on the hematological and liver indices. Materials and Methods: A cross-sectional study was conducted on patients at the Thalassemia Center in Sulaymaniyah, Iraq. The study included 76 β,-thalassemia major children (37 females and 39 males, with a median age of 6 years). The patients were divided into Group I (n = 51, treated with deferasirox) and Group II (n = 25, treated with deferoxamine). Complete blood count and liver enzymes (alanine [ALT] and aspartate [AST] aminotransferase) were determined,the hemoglobin densities were calculated to differentiate absolute from restrictive iron deficiency,and the fibrosis-4 score (FIB-4, aspartate-to-platelet ratio index (APRI), and (AST/ALT ratio) were calculated. Results: Hemoglobin density indices showed restricted iron deficiency in both treated groups. However, serum ferritin level was higher in Group II than in Group I (1. 9 times higher, p=0. 037). Also, the median value of MCV in Group II was significantly higher than in Group I (79. 8 fL vs. 77. 0 fL, respectively). In contrast, liver fibrosis indices defined with the mean values of AST-to-ALT ratio and FIB-4 score were higher in Group I compared to Group II. A positive and significant correlation was observed between APRI level and serum ferritin in Group I (r = 0. 518, df = 49, p<0. 001). Conclusions: Based on the data, it can be concluded that both deferasirox and deferoxamine affect red blood cells parameters, which may be related to their function as ICAs, leaing to temporary iron deficiency in treated patients. Both drugs may induce inconsistent changes in the liver which are highly associated with circulating ferritin level. However, the destructive effect of deferasirox on the liver is more evident, leading to the induction of fibrosis.

Multimedia

No record.

Cites

No record.

References

Cite

APA: Copy

Al Nimer, Marwan S., Hamasalih, Raz M., & Ratha, Rawa. (2023). Effects of deferoxamine versus deferasirox on hematology and liver parameters in children with beta-thalassemia major: A cross-sectional study from a single center. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 13(4), 251-259. SID. https://sid.ir/paper/1087257/en

Vancouver: Copy

Al Nimer Marwan S., Hamasalih Raz M., Ratha Rawa. Effects of deferoxamine versus deferasirox on hematology and liver parameters in children with beta-thalassemia major: A cross-sectional study from a single center. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY[Internet]. 2023;13(4):251-259. Available from: https://sid.ir/paper/1087257/en

IEEE: Copy

Marwan S. Al Nimer, Raz M. Hamasalih, and Rawa Ratha, “Effects of deferoxamine versus deferasirox on hematology and liver parameters in children with beta-thalassemia major: A cross-sectional study from a single center,” IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, vol. 13, no. 4, pp. 251–259, 2023, [Online]. Available: https://sid.ir/paper/1087257/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops